Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis

Microvascular Research

Volumn 63, Issue 3, 2002, Pages 304-315

  Haspel, Howard C ^a,c   Scicli, Gloria M ^a   McMahon, Gerald ^b   Scicli, A Guillermo ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b SUGEN INC   (United States)

^c Research and Development   (United States)

Author keywords

CD31; Flk 1; Flt 1; PECAM 1

Indexed keywords

CD31 ANTIGEN; CELL MARKER; COLLAGEN; MATRIGEL; PROTEIN TYROSINE KINASE; SEMAXANIB; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANASTOMOSIS; ANGIOGENESIS; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BIOCHEMISTRY; CAPILLARY; CELL AGGREGATION; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; HEART; IN VITRO STUDY; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPHEROID CELL;

EID: 0036353587     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.2001.2383     Document Type: Article

References (31)

1. Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium: A study of aortic and microvascular endothelial cell lines
2. Phenotypic modulations of human umbilical vein endothelial cells and human dermal fibroblasts using two angiogenic assays
3. New paradigms for the treatment of cancer: The role of anti-angiogenesis agents
4. Fibroblast growth factor 2 activation of stromal cell vascular endothelial growth factor expression and angiogenesis
5. Involvement of endothelial PECAM-1/CD31 in angiogenesis
6. Thrombin-induced association of SHP-2 with multiple tyrosine-phosphorylated proteins in human platelets
7. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types
8. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development
9. Biosynthesis and processing of the cell adhesion molecule CD31 includes production of a soluble form
10. Heterogeneity of mouse vascular endothelium: In vitro studies of lymphatic, large blood vessel and microvascular endothelial cells
11. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
12. CD31 functions as a reservoir for and a modulator of tyrosine-phosphorylated beta-catenin
13. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation
14. Tensional forces in fibrillar extracellular matrices control directional capillary sprouting
15. Blood vessel maturation in a 3-dimensional spheroidal coculture model: Direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness
16. Differential effects of interferon gamma and alpha on in vitro model of angiogenesis
17. VEGF receptor signaling in tumor angiogenesis
18. A microcarrier-based cocultivation system for the investigation of factors and cells involved in angiogenesis in three-dimensional fibrin matrices in vitro
19. The biology of PECAM-1
20. CD31 exists as a dimer and is heavily N-glycosylated
21. Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: A comparative study of angiogenesis in matrigel, collagen, fibrin, and plasma clot
22. A hemangioendothelioma-derived cell line: Its use as a model for the study of endothelial cell biology
23. Differential control of the functional cell surface expression and content of hexose transporter GLUT-1 by glucose and glucose metabolism in murine fibroblasts
24. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling
25. Manipulating angiogenesis: From basic science to the bedside
26. Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis
27. Inhibition of tumor angiogenesis by synthetic receptor tyrosine kinase inhibitors
28. Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases
29. Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy
30. A novel, quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matrices
31. CD31: Its expression and function as a cell adhesion molecule on hematopoietic and endothelial cells